{
  "cik": 1789972,
  "cik_padded": "0001789972",
  "entityName": "Cullinan Therapeutics, Inc.",
  "fiscal_years": [
    {
      "accn": "0001193125-26-099362",
      "filed": "2026-03-10",
      "fiscal_year": 2025,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 49000.0,
        "cash": 88332000.0,
        "free_cash_flow": -175799000.0,
        "net_income": -219879000.0,
        "operating_cash_flow": -175750000.0,
        "operating_income": -241648000.0,
        "stockholders_equity": 408730000.0,
        "total_assets": 448374000.0,
        "total_liabilities": 39644000.0
      },
      "period_end": "2025-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.0969931250458738,
        "roa_avg2y": -0.41091274698700614,
        "roa_period_end": -0.4903919495778078,
        "roe_avg2y": -0.44017264262935685,
        "roe_period_end": -0.537956597264698
      }
    },
    {
      "accn": "0001193125-26-099362",
      "filed": "2026-03-10",
      "fiscal_year": 2024,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 0.0,
        "cash": 83005000.0,
        "free_cash_flow": -145303000.0,
        "net_income": -167383000.0,
        "operating_cash_flow": -145303000.0,
        "operating_income": -196919000.0,
        "stockholders_equity": 590328000.0,
        "total_assets": 621824000.0,
        "total_liabilities": 31496000.0
      },
      "period_end": "2024-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.05335338997980783,
        "roa_avg2y": -0.3026800939597073,
        "roa_period_end": -0.26918066848497324,
        "roe_avg2y": -0.32064756697837515,
        "roe_period_end": -0.28354236966567736
      }
    },
    {
      "accn": "0000950170-25-028346",
      "filed": "2025-02-27",
      "fiscal_year": 2023,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 208000.0,
        "cash": 98434000.0,
        "free_cash_flow": -134483000.0,
        "net_income": -153162000.0,
        "operating_cash_flow": -134275000.0,
        "operating_income": -191089000.0,
        "stockholders_equity": 453703000.0,
        "total_assets": 484182000.0,
        "total_liabilities": 30287000.0
      },
      "period_end": "2023-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.06675512394672285,
        "roa_avg2y": -0.2930491658367606,
        "roa_period_end": -0.3163314621361389,
        "roe_avg2y": -0.30981499536780444,
        "roe_period_end": -0.33758207461709533
      }
    },
    {
      "accn": "0000950170-24-031143",
      "filed": "2024-03-14",
      "fiscal_year": 2022,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 1133000.0,
        "cash": 156152000.0,
        "free_cash_flow": -127797000.0,
        "net_income": 111214000.0,
        "operating_cash_flow": -126664000.0,
        "operating_income": 144648000.0,
        "stockholders_equity": 535029000.0,
        "total_assets": 561117000.0,
        "total_liabilities": 26088000.0
      },
      "period_end": "2022-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.04875997375843179,
        "roa_avg2y": 0.22280632514008786,
        "roa_period_end": 0.19820108818659926,
        "roe_avg2y": 0.23169583333333332,
        "roe_period_end": 0.20786536804547043
      }
    },
    {
      "accn": "0000950170-23-006839",
      "filed": "2023-03-09",
      "fiscal_year": 2021,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 0.0,
        "cash": 59774000.0,
        "free_cash_flow": -43433000.0,
        "net_income": -65570000.0,
        "operating_cash_flow": -43433000.0,
        "operating_income": -67954000.0,
        "stockholders_equity": 424971000.0,
        "total_assets": 437185000.0,
        "total_liabilities": 11811000.0
      },
      "period_end": "2021-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.0277924846636594,
        "roa_avg2y": -0.2011679830892493,
        "roa_period_end": -0.1499822729508103,
        "roe_avg2y": -0.21016665571547852,
        "roe_period_end": -0.15429288116130277
      }
    },
    {
      "accn": "0000950170-22-004002",
      "filed": "2022-03-17",
      "fiscal_year": 2020,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 10000.0,
        "cash": 168198000.0,
        "free_cash_flow": -29782000.0,
        "net_income": -51799000.0,
        "operating_cash_flow": -29772000.0,
        "operating_income": -60335000.0,
        "stockholders_equity": 199010000.0,
        "total_assets": 214708000.0,
        "total_liabilities": 14394000.0
      },
      "period_end": "2020-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.07232802371740113,
        "roa_period_end": -0.24125323695437526,
        "roe_avg2y": -0.3499802372209141,
        "roe_period_end": -0.2602834028440782
      }
    },
    {
      "accn": "0000950170-22-004002",
      "filed": "2022-03-17",
      "fiscal_year": 2019,
      "form": "10-K",
      "fundamental_units": {
        "stockholders_equity": "USD"
      },
      "fundamentals": {
        "stockholders_equity": 97001000.0
      },
      "period_end": "2019-12-31",
      "ratios": {}
    }
  ],
  "latest_filing": {
    "accn": "0001193125-26-099362",
    "filed": "2026-03-10",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "2836",
  "sic_description": "Biological Products, (No Diagnostic Substances)",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001789972.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0001789972.json"
  },
  "ticker": "CGEM"
}